These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS. Istl AC; Ruck JM; Morris CD; Levin AS; Meyer CF; Johnston FM J Surg Oncol; 2019 Jun; 119(7):824-835. PubMed ID: 30737793 [TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials]. Budach V Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407 [No Abstract] [Full Text] [Related]
9. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Schuetze SM; Patel S Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770 [TBL] [Abstract][Full Text] [Related]
10. Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. Hua Q; Xu G; Zhao L; Zhang T J Chemother; 2021 Sep; 33(5):319-327. PubMed ID: 33501892 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Woll PJ; Reichardt P; Le Cesne A; Bonvalot S; Azzarelli A; Hoekstra HJ; Leahy M; Van Coevorden F; Verweij J; Hogendoorn PC; Ouali M; Marreaud S; Bramwell VH; Hohenberger P; Lancet Oncol; 2012 Oct; 13(10):1045-54. PubMed ID: 22954508 [TBL] [Abstract][Full Text] [Related]
13. Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. Charlson J Curr Treat Options Oncol; 2018 Oct; 19(12):65. PubMed ID: 30361919 [TBL] [Abstract][Full Text] [Related]
14. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy. Brandts CH; Schulz C; Willich N; Steffen B; Hardes J; Gosheger G; Winkelmann W; Serve H; Heinecke A; Berdel WE; Thomas M Cancer Chemother Pharmacol; 2012 Mar; 69(3):613-20. PubMed ID: 21947168 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Tierney JF; Mosseri V; Stewart LA; Souhami RL; Parmar MK Br J Cancer; 1995 Aug; 72(2):469-75. PubMed ID: 7640234 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Bramwell VH; Anderson D; Charette ML; Cochrane Database Syst Rev; 2003; 2003(3):CD003293. PubMed ID: 12917960 [TBL] [Abstract][Full Text] [Related]
18. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out? Pisters PW J Clin Oncol; 2006 Feb; 24(4):549-51. PubMed ID: 16446327 [No Abstract] [Full Text] [Related]
19. [Adjuvant chemotherapy of soft tissue sarcoma]. Lévy E; Thirion P; Piedbois P Cancer Radiother; 1997; 1(5):462-6. PubMed ID: 9587378 [TBL] [Abstract][Full Text] [Related]
20. Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation. Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H BMC Cancer; 2019 Jan; 19(1):56. PubMed ID: 30634944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]